iPSCs (Induced Pluripotent Stem Cells) serve as a “raw material” for therapy and research since they induce various organ-specific cells or tissues (retina, liver, heart, kidney, etc.).These cells play a vital role in future regenerative medicine, enabling disease modelling, drug discovery, testing and repurposing. Join Cellagility Biomed on a journey to derive, evaluate, store and supply iPSCs playing a role in driving economic growth servicing a new healthcare vision making stem cell treatments more accessible.